Search Results - "Gómez, P Nieto"

Analysis of oncological drugs authorised in Spain in the last decade: association between clinical benefit and reimbursement by Nieto-Gómez, P., Castaño-Amores, C., Rodríguez-Delgado, A., Álvarez-Sánchez, R.

“…Background Our study aimed to assess whether there was a relationship between clinical benefits and reimbursement decisions as well as the inclusion of…”
Get full text

Efficacy of enzalutamide and apalutamide in the treatment of non-metastasic castration-resistant prostate cancer: Indirect comparison by Nieto-Gómez, P, Ubago-Pérez, R, Cabeza-Barrera, J

“…OBJECTIVESTo perform an adjusted indirect comparison of the efficacy of enzalutamide and apalutamide in patients with non-metastatic castration-resistant…”
Get full text

Efficacy of enzalutamide and apalutamide in the treatment of non-metastasic castration-resistant prostate cancer: Indirect comparison by Nieto-Gómez, P., Ubago-Pérez, R., Cabeza-Barrera, J.

“…To perform an adjusted indirect comparison of the efficacy of enzalutamide and apalutamide in patients with non-metastatic castration-resistant prostate cancer…”
Get full text

4CPS-310 Tofacitinib effectiveness and safety results: real world data by Álvarez Sánchez, R, Castaño-Amores, C, Nieto Gómez, P, Rodriguez Delgado, A, Portillo Haro, S, Moreno Rodriguez, P, Cabeza Barrera, J

“…Background and importanceTofacitinib is an oral JAK inhibitor indicated for the treatment of rheumatoid arthritis, psoriasis arthritis and ulcerative colitis…”
Get full text

4CPS-020 Use and effectiveness of carboxymaltose iron and isomaltoside iron by Gómez, P Nieto, Sanchez, R Alvarez, Raya, P Moreno, Delgado, A Rodriguez

“…BackgroundCarboxymaltoside-iron (CMI)and isomaltoside-iron (IMI)have both indications for the treatment of iron deficiency when oral preparations are…”
Get full text

4CPS-082 Evaluation of effectiveness of darunavir/cobicistat monotherapy in hiv patients by Gómez, P Nieto, Moreno, P, Corpas, M Valle, Hidalgo, I Casas, Delgado, A Rodriguez, Sanchez, R Alvarez, Fernandez, C García

“…BackgroundHIV therapies are usually based on the action of various antiretroviral drugs coadministered in order to achieve a good virologic (viral loads<50…”
Get full text

4CPS-083 Evaluation of cardiovascular risk in patients on darunavir/cobicistat monotherapy treatment by Gómez, P Nieto, Delgado, A Rodriguez, Hidalgo, I Casas, Moreno, P, Corpas, M Valle, Rustarazo, S Belda

“…BackgroundSome of the most common adverse effects of protease inhibitors in treatment of HIV are dislypidaemia, diabetes and other metabolic disorders. These…”
Get full text

4CPS-203 Evaluation of efficiency and clinical improvements of pharmaceutical interventions in a recently implemented social-sanitary centre by Gómez, P Nieto, Rustarazo, S Belda, Fernández, C García, Sánchez, R Alvarez, Delgado, A Rodriguez

“…BackgroundSocial sanitary centres (SSC) are resources that coordinate healthcare and psychosocial care to groups of dependent patients such as elderly people,…”
Get full text

4CPS-005 GLP-1 agonist liraglutide as add-on therapy in type 2 diabetes by Blánquez Martínez, D, Hayon Ponce, M, Casas Hidalgo, I, Diaz Villamarin, X, Raquel, ÁS, Nieto Gómez, P, Davila Fajardo, C

“…BackgroundPurposeThe aim of this study was to evaluate the real-world efficacy and safety of adding Liraglutide in inadequately controlled patients with oral…”
Get full text

4CPS-011 Prevalence and relationship between hypovitaminosis D and insulin resistance in obese patient candidates for bariatric surgery by Blánquez Martínez, D, Hayon Ponce, M, Nieto Gómez, P, Raquel, ÁS, Diaz Villamarin, X, Garcia Fernandez, C, Davila Fajardo, C

“…BackgroundLow vitamin D levels have been postulated to be associated with insulin resistance, suggesting that vitamin D plays a role in glucose metabolism and…”
Get full text

5PSQ-028 Cardiovascular risk factor in individuals with gender identity disorder or cross-sex hormone therapy by Martínez, D Blánquez, Ponce, M Hayon, Romero, A Caballero, Villamarin, X Diaz, Gómez, P Nieto, Raya, P Moreno, Delgado, A Rodriguez, Sanchez, R Alvarez, Fajardo, C Davila

“…BackgroundCross-sex hormone therapy (CHT) is known to lead to alterations in the cardiovascular risk factor (CVRF).PurposeTo assess changes in lipid profile…”
Get full text

5PSQ-012 Prescription of dabigatran in the elderly population by López-Sepúlveda, R, Soto, C Valencia, Rodríguez-Hermida, F Artime, Gómez, P Nieto, Herrera, S Guijarro, Lirola, MA García, García, E Espínola, Barrera, J Cabeza

“…BackgroundAtrial fibrillation (AF) is a common clinical problem, particularly in the elderly. Dabigatran is indicated for the prevention of stroke and systemic…”
Get full text

4CPS-103 Second-generation tyrosin kinase inhibitors in front-line therapy. comparing responses by Soto, CM Valencia, López-Sepúlveda, R, Artime-Rodríguez-Hermida, F, Herrera, S Guijarro, Villacañas-Palomares, MV, Gómez, P Nieto, Miguel, S Cortes-de

“…BackgroundSecond-generation tyrosine kinase inhibitors(2G-TKI) have increased considerably over the past few years. Despite good and maintained results with…”
Get full text

OHP-026 Prophylactic treatment of chronic migraine with botulinum toxin: study population by Fernández, C García, Peña, C Gómez, Rustarazo, S Belda, Delgado, A Rodriguez, Hidalgo, I Casas, Medina, MDC Gonzalez, Gómez, P Nieto

“…BackgroundIn different clinical studies, the use of botulinum toxin has shown a reduction in health spending, reducing the number of drugs used for patients…”
Get full text

4CPS-077 Genetic variants affecting bisoprolol response in cardiovascular diseases by Castaño-Amores, C, Nieto-Gómez, P, Portillo-Haro, S, Nieto, MT, Díaz-Villamarín, X, Dávila-Fajardo, CL

“…Background and importanceβ-Blockers are commonly prescribed to treat multiple cardiovascular (CV) diseases, but, frequently, adverse drug reactions and…”
Get full text

2SPD-013 Economic impact of biosimilar infliximab use by García-Fernandez, C, Ruiz-Fuentes, S, Belda-Rustarazo, S, Gómez-Peña, C, Morón-Romero, R, Gómez-Nieto, P

“…BackgroundThe prescriptions of biologics are increasing as new indications and drugs are authorised. Since biosimilar drugs were introduced in the…”
Get full text